Trials / Sponsors / AC Immune SA
AC Immune SA
Industry · 8 registered clinical trials — 4 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | A Study Investigating the Safety, Absorption, Elimination, and the Effect on the Immune System of ACI-19764 in Healthy Participants | Phase 1 | 2026-01-28 |
| Recruiting | [18F]ACI-15916 PET in α-synucleinopathies Parkinson's Disease (PD), Multiple System Atrophy (MSA), Dementia With Lewy Bodies (DLB) | EARLY_Phase 1 | 2025-03-20 |
| Recruiting | [18F]ACI-19626 PET in TDP-43 Proteinopathies Frontotemporal Dementia (FTD), Amyotrophic Lateral Sclerosis (ALS), TDP-43 Proteinopathies | EARLY_Phase 1 | 2025-01-21 |
| Active Not Recruiting | A Study to Evaluate the Effects of ACI-7104.056 in Patients With Early Stages of Parkinson's Disease Parkinson Disease, Parkinson Disease 6, Early-Onset | Phase 2 | 2023-07-24 |
| Recruiting | A Study to Assess the Effects of ACI-24.060 in Alzheimer's Disease and in Down Syndrome (ABATE Study) Amyloid Plaque, Beta-Amyloid, DSAD | Phase 1 / Phase 2 | 2022-06-21 |
| Withdrawn | A Study of ACI-24 in Adults With Down Syndrome Down Syndrome | Phase 2 | 2021-10-01 |
| Completed | A Study to Evaluate the Safety, Tolerability and Immunogenicity of Tau Targeted Vaccines in Participants With Alzheimer's Disease, Cognitive Impairment, Tauopathies | Phase 1 / Phase 2 | 2019-07-31 |
| Completed | Safety, Tolerability and Immunogenicity of ACI-24 Vaccine in Adults With Down Syndrome Down Syndrome | Phase 1 | 2016-03-01 |